caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1588823744

Che-Kai TsaoM.D.

Medical OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Che-Kai Tsao's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MOUNT SINAI HOSPITAL991,120
MOUNT SINAI HOSPITAL2894
Howard Greenberg
Hematology-Oncology · New York, NY
2082
Marjorie Stein
Diagnostic Radiology · Elmhurst, NY
1751
New York City Health And Hospitals Corporation
Ambulance Service Provider · Brooklyn, NY
1727
Scott Stickles
Diagnostic Radiology · Elmhurst, NY
1433
Mark Choi
Diagnostic Radiology · Elmhurst, NY
1323
Chirag Vasa
Infectious Disease · Astoria, NY
1128
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
213
Unique beneficiaries
—
Total services
457
Distinct HCPCS
5
Medicare payment
$45K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — above median (cohort median 458).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$7K
Payment records
8
By payment type
Consulting Fee$6K
Food and Beverage$275
PRESCRIBING · PART D · 2024
Total Rx claims
716
Beneficiaries
—
Total drug cost
$4.6M
Distinct drugs
16
Brand share
69.6%
Top prescribed drugs
Relugolix203 claims
Darolutamide185 claims
Tamsulosin Hcl46 claims
Enzalutamide41 claims
Apalutamide37 claims